TNG Pharmaceuticals, Inc.

New Filing
CIK: 0001583185·Other·DELAWARE·Filed: Aug 5, 2013
Total Offering

$4,500,000

Amount Sold

$2,644,346

Investors

22

First Sale

Aug 2, 2013

Offering Details

Type
Equity
Exemptions
Rule 506
Entity Type
Corporation
Year Incorporated
2011
Non-Accredited Investors
No

Related Persons

NameRole
Larry Horn
Related Person
Jennifer Corbin
Related Person
Serge Martinod
Related Person
Phoebe Wood
Related Person
Butch Mercer
Related Person
Kent Van Kampen
Related Person

Company

TNG Pharmaceuticals, Inc.

201 E JEFFERSON STREET

LOUISVILLE, KY, 40202

888-345-0878

SEC Filing

0000911959-13-000034

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
TNG Pharmaceuticals, Inc. Form D Filing — $4,500,000 | FilingFlow